Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features
Open Access
- 14 August 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 85 (4) , 538-545
- https://doi.org/10.1054/bjoc.2001.1937
Abstract
The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.Keywords
This publication has 29 references indexed in Scilit:
- Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breastHistopathology, 2000
- Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cellsProceedings of the National Academy of Sciences, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formationOncogene, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Distinctive gene expression patterns in human mammary epithelial cells and breast cancersProceedings of the National Academy of Sciences, 1999
- Epidemiology, prevention, and early detection of breast cancerCurrent Opinion in Oncology, 1997
- BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsNature Genetics, 1997
- TP53 andMYC gene alterations independently predict poor prognosis in breast cancer patientsGenes, Chromosomes and Cancer, 1996
- Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNAEuropean Journal of Biochemistry, 1980